The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients ...
Adjuvant therapy with Imfinzi (durvalumab) and Imjudo (tremelimumab-actl) in patients with resected renal cell carcinoma was ...
Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...
MedPage Today on MSN
Quality-of-Life Outcomes Underreported in GU Cancer Trials
Of the phase III trials that planned to report QoL outcomes, nearly 40% never did ...
Results presented here showed negative pressure wound therapy is a safe adjunct for soft tissue sarcoma treated with ...
NEW ORLEANS -- Most patients undergoing knee replacement procedures also have joint pain elsewhere, diminishing their overall ...
Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...
Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last Each team from nine jurisdictions submitted a final report describing their PROM implementation project. Reports ...
Patient Portals to Elicit Essential Patient-Reported Elements of Communication Supporting Person-Centered Oncologic Care: A Pilot Study of the PERSON Approach By implementing ePRO for symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results